Bottom line
SPXV vs PRHSX: the short answer
SPXV (ProShares S&P 500 Ex-Health Care ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs.
SPXV is cheaper at 0.09% vs 0.83% — a difference of $74 a year per $10,000 invested.
Over five years, SPXV returned +15.1% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
SPXV vs PRHSX side by side
| SPXV | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.83% |
| Annual cost per $10k | $9 | $83 |
| 10-yr cost on $10k (prospectus) | $162 | $1,025 |
| Max front load | None | — |
| 12b-1 fee | — | — |
| 1-yr return | +18.1% | +17.7% |
| 5-yr return (annualized) | +15.1% | +4.2% |
| 10-yr return (annualized) | — | +9.1% |
| Best quarter | +21.7% | +23.5% |
| Worst quarter | −20.7% | −15.8% |
| Net assets (fund) | $40.2M | $11.9B |
| Number of holdings | 449 | 279 |
| Portfolio turnover | 4% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPXV | PRHSX | Difference |
|---|---|---|---|
| 2025 | +18.1% | +17.7% | +0.4% |
| 2024 | +28.0% | +1.8% | +26.2% |
| 2023 | +30.7% | +3.1% | +27.6% |
| 2022 | −20.6% | −12.2% | −8.4% |
| 2021 | +28.7% | +13.3% | +15.4% |
| 2020 | +18.9% | +30.1% | −11.2% |
| 2019 | +33.0% | +29.1% | +3.9% |
| 2018 | −6.4% | +1.2% | −7.6% |
| 2017 | +21.4% | +28.0% | −6.6% |
| 2016 | +14.2% | −10.4% | +24.5% |
Source: Fund prospectus bar charts
Holdings overlap
SPXV and PRHSX share none of their top holdings.
SPXV top 10
- NVIDIA Corp. — 8.60%
- Apple, Inc. — 7.68%
- Microsoft Corp. — 5.60%
- Amazon.com, Inc. — 4.43%
- Alphabet, Inc. — 3.71%
- Broadcom, Inc. — 3.55%
- Alphabet, Inc. — 2.95%
- Meta Platforms, Inc. — 2.32%
- Tesla, Inc. — 2.05%
- Micron Technology, Inc. — 1.83%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between SPXV and PRHSX?
SPXV (ProShares S&P 500 Ex-Health Care ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both etfs. SPXV is cheaper at 0.09% vs 0.83% — a difference of $74 a year per $10,000 invested.
Which is cheaper, SPXV or PRHSX?
SPXV has the lower expense ratio (0.09%).
Should I own both SPXV and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.